Skip to content
2000
Volume 23, Issue 11
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

The therapeutic significance of bioengineering proteins has increased dramatically as a new generation of pharmacological drug with a great potential in medical treatment. Protein engineering has improved the use of new non immunoglobulin affinity proteins. The designed ankyrin repeat proteins abbreviated as DARPins is a classical example. These molecules have smaller structural size, unlike immunoglobulins, but similar target affinity is of great significance. Such molecules get more binding specificity and greater thermodynamic stability. These attributes made DARPins a favorite player in diagnostics and therapeutics of cancer. How DARPins are improved into vigorous and versatile scaffold for binding protein and selected by ribosome and phage display along with related aspects is discussed in this review.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612822666161208121829
2017-03-01
2025-05-29
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612822666161208121829
Loading

  • Article Type:
    Research Article
Keyword(s): Designed ankyrin repeat proteins; Protein bioengineering; Therapeutics
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test